Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Dr. Prem Aggarwal

Dr Prem Aggarwal, (MD Medicine, DNB Cardiology) is a Cardiologist by profession and also the Co-founder and Chairman of Medical. He focuses on news and perspectives about cardiology, and medicine related developments at Medical Dialogues. He can be reached out at drprem@medicaldialogues.in

Home

Dr. Prem Aggarwal

Articles By : Dr. Prem Aggarwal

Nuts and Bolts of latest Hypertension Guidelines - The emphasis on combination therapy

Dr. Prem Aggarwal6 Aug 2021 12:45 PM IST

Hypertension, marked as a disorder with invading effects, shows increasing prevalence in different forms all across the globe. For example, in India...

Amlodipine and Telmisartan combination offers swift, effective BP control along with end-organ protection in hypertensive patients with diabetes: Study

Dr. Prem Aggarwal7 July 2021 12:45 PM IST

Hypertension and diabetes - the deadly duo!Hypertension or high blood pressure (BP), the leading cause of mortality, affects nearly 1.39 billion...

Obituary: Eminent Cardiologist, Teacher, Speaker- Padma Shri Dr KK Aggarwal no more

Dr. Prem Aggarwal18 May 2021 11:08 AM IST

New Delhi: The entire medical fraternity noted a big loss today with the passing of renowned Cardiologist, teacher, and speaker Padma Shri Dr KK...

Nifedipine revisited: Extended-release formulations superior in patients with coronary artery disease, shows study

Dr. Prem Aggarwal30 April 2021 12:45 PM IST

Coronary artery disease has been on a spiked rise owing to stressful lifestyles, coupled with unhealthy food choices and lack of regular exercise. The...

Amlodipine, Telmisartan Combination better than Monotherapy: TEAMSTA 5 Study

Dr. Prem Aggarwal13 April 2021 12:45 PM IST

The hypertensive pressure continues to mount!Hypertension or high blood pressure (BP) affects 1.39 billion people worldwide. Nearly 25% men and...

Avoiding Aldosterone Breakthrough in Hypertensive Diabetics: Role of Azelnidipine

Dr. Prem Aggarwal28 Dec 2020 12:30 PM IST

Azelnidipine may contribute to avoid the "aldosterone breakthrough" by its suppressive effects on aldosterone synthesis and secretion

Impact of Azelnidipine in reducing urinary albumin excretion and carotid atherosclerosis in type 2 diabetes patients: BOAT 2 study Review

Dr. Prem Aggarwal15 Dec 2020 12:45 PM IST

Hypertension and Diabetes Mellitus are the global health burden and strong risk factors for coronary artery disease (1). Impaired glucose tolerance...

Azelnidipine versus Amlodipine in hypertensive diabetics with albuminuria: Review

Dr. Prem Aggarwal27 Nov 2020 12:45 PM IST

Hypertension is common among diabetics and those who have chronic kidney disease. Both hypertension and diabetes are associated with increased...

Single-pill Triple Drug combination of Perindopril, Indapamide, Amlodipine shows robust efficacy, safety in Indian patients: JAPI

Dr. Prem Aggarwal24 Nov 2020 10:00 AM IST

A triple-drug single-pill combination (SPC) containing Perindopril, Indapamide, and Amlodipine has shown excellent safety, efficacy as well as...

Role of Azelnidipine on management of BP in hypertensive Diabetics: Review

Dr. Prem Aggarwal4 Nov 2020 11:09 AM IST

Hypertensive patients with type 2 diabetes carry a high cardiovascular risk. Most patients with hypertension and diabetes face higher mortality due to...

Hypertension: ACEIs more effective in BP control and central hemodynamic improvement than ARBs, finds KGMU study

Dr. Prem Aggarwal15 Oct 2020 12:04 PM IST

New Delhi: High Blood Pressure (BP) patients treated with ACEIs versus ARBs showed a more effective improvement with ACEIs in the majority of...

BPLTTC: Using Antihypertensive agents as risk modifiers for prevention of CV events irrespective of baseline criteria: Scope of Amlodipine

Dr. Prem Aggarwal13 Oct 2020 12:17 PM IST

Hypertension, a prominent cause of premature mortality, affects ~1.13 billion people worldwide, though blood pressure (BP) control rates remain dismal...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok